Effect [qlco]
Hormone replacement therapy [topp]
Lipoprotein (a) [aapp, bacs]
Lipid level [lbtr]
postmenopausal [tmco]
Women [popg]
influential [idcn]
Various [irda]
Progestogens [horm, phsu, strd]
Duration [tmco]
therapy [ftcn]
Background [cnce]
Estrogen Replacement Therapy [topp]
Post-Menopause [orgf]
Women [popg]
Risk [qlco]
coronary artery disease [dsyn]
One [qnco]
Possible [qlco]
Mechanisms [ftcn]
Effect [qlco]
Modification [ftcn]
Lipid [lipd]
Profile [lbpr]
controversy [socb]
Concern [idcn]
effects [qlco]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Lipid level [lbtr]
Progestogens [horm, phsu, strd]
Administered [ftcn]
Estrogen [horm, phsu, strd]
Methods [inpr]
Five [qnco]
One [qnco]
postmenopausal [tmco]
Women [popg]
divided [ftcn]
Group [idcn]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
N NOS [aapp, imft]
mg% [qnco]
Of [spco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
mg% [qnco]
Acetate [orch, phsu]
N NOS [aapp, imft]
mg% [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
mg% [qnco]
Of [spco]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
mg% [qnco]
valerate [lipd]
Plus [qlco]
Norgestrel [horm, phsu, strd]
N NOS [aapp, imft]
Group [idcn]
Control [grup]
N NOS [aapp, imft]
Lp(a) [aapp, bacs]
Lipid level [lbtr]
Measured [qlco]
months [tmco]
Hormone replacement therapy [topp]
Result [ftcn]
Estrogen Replacement Therapy [topp]
months [tmco]
lowered [spco]
Lp(a) [aapp, bacs]
Level [qlco]
Addition [ftcn]
Progestagen [horm, phsu, strd]
Attenuated [qlco]
Lp(a) [aapp, bacs]
lowering [spco]
Effect [qlco]
Estrogen [horm, phsu, strd]
High density lipoprotein cholesterol level [lbpr]
Markedly [qlco]
Increased [qnco]
Moderately [qlco]
Increased [qnco]
Not [ftcn]
Changed [ftcn]
Low density lipoprotein cholesterol level [lbpr]
Decreased [qnco]
treatment [ftcn]
Group [idcn]
Estrogen Replacement Therapy [topp]
months [tmco]
Raised [qnco]
High density lipoprotein cholesterol level [lbpr]
Group [idcn]
Combined therapy [topp]
Estradiol + norgestrel [horm, phsu, strd]
Plus [qlco]
High density lipoprotein cholesterol level [lbpr]
Decreased [qnco]
Not [ftcn]
Changed [ftcn]
months [tmco]
Group [idcn]
Received [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
mg% [qnco]
Acetate [orch, phsu]
Show [inpr]
Intermediate [spco]
effects [qlco]
Group [idcn]
Received [qlco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Only [qnco]
Group [idcn]
Received [qlco]
Estradiol + norgestrel [horm, phsu, strd]
Plus [qlco]
Conclusions [idcn]
Combined [qlco]
Estrogen [horm, phsu, strd]
Progestagen [horm, phsu, strd]
therapy [ftcn]
effects [qlco]
Heart [bpoc]
Different [qlco]
estrogen therapy [topp]
Alone [qnco]
IMPACT [gngm]
Progestogens [horm, phsu, strd]
Lp(a) [aapp, bacs]
High density lipoprotein cholesterol level [lbpr]
effects [qlco]
progesterones [horm, phsu, strd]
Dependent [qlco]
Androgen [horm, phsu]
Potential [qlco]
Progestagen [horm, phsu, strd]
Duration [tmco]
therapy [ftcn]
